Literature DB >> 20063316

Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer.

Wenjie Dong1, Xiaobing Chen, Jing Xie, Pinghu Sun, Yunlin Wu.   

Abstract

Hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI-2/SPINT2) encodes Kunitz-type protease inhibitor that regulates HGF activity. Inspection of the human HAI-2/SPINT2 locus uncovered a large and dense CpG island within the 5' region of this gene. Analysis of cultured human gastric tumor lines indicated that HAI-2/SPINT2 expression is either undetectable or in low abundance in several lines; however, enhanced gene expression was measured in cells cultured on the DNA demethylating agent 5-aza-2'-deoxycytidine. Bisulfite DNA sequencing confirmed the densely methylated HAI-2/SPINT2 promoter region. Forced expression of HAI-2/SPINT2 induced cell apoptosis, suppressed anchorage independent growth in vitro and tumor growth in vivo. We investigated HAI-2/SPINT2 aberrant methylation in patients with gastric cancer. The HAI-2/SPINT2 methylation was found preferentially in cancerous tissues (30 of 40, 75%) compared with nontumor tissues (no methylation was detected), indicating that this aberrant characteristic is common in gastric malignancies. In conclusion, epigenetic inactivation of HAI-2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063316     DOI: 10.1002/ijc.25161

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Inactivation of MYO5B promotes invasion and motility in gastric cancer cells.

Authors:  Wenjie Dong; Xiaobing Chen; Ping Chen; Dongli Yue; Linan Zhu; Qingxia Fan
Journal:  Dig Dis Sci       Date:  2011-12-02       Impact factor: 3.199

2.  Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2.

Authors:  Márcia Santos Pereira; Sónia Pires Celeiro; Ângela Margarida Costa; Filipe Pinto; Sergey Popov; Gisele Caravina de Almeida; Júlia Amorim; Manuel Melo Pires; Célia Pinheiro; José Manuel Lopes; Mrinalini Honavar; Paulo Costa; José Pimentel; Chris Jones; Rui Manuel Reis; Marta Viana-Pereira
Journal:  Cell Oncol (Dordr)       Date:  2019-11-07       Impact factor: 6.730

3.  SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.

Authors:  Fei Liu; Christopher D Cox; Reshmi Chowdhury; Laura Dovek; Huytram Nguyen; Tie Li; Sichen Li; Byram Ozer; Arthur Chou; Nhung Nguyen; Bowen Wei; Joseph Antonios; Horacio Soto; Harley Kornblum; Linda Liau; Robert Prins; P Leia Nghiemphu; William Yong; Timothy Cloughesy; Albert Lai
Journal:  J Neurooncol       Date:  2019-03-05       Impact factor: 4.130

4.  MYO5B is epigenetically silenced and associated with MET signaling in human gastric cancer.

Authors:  Wenjie Dong; Liping Wang; Ruizhe Shen
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

5.  Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells.

Authors:  Eun-Joon Lee; Prakash Rath; Jimei Liu; Dungsung Ryu; Lirong Pei; Satish K Noonepalle; Austin Y Shull; Qi Feng; N Scott Litofsky; Douglas C Miller; Douglas C Anthony; Mark D Kirk; John Laterra; Libin Deng; Hong-Bo Xin; Xinguo Wang; Jeong-Hyeon Choi; Huidong Shi
Journal:  J Genet Genomics       Date:  2015-06-24       Impact factor: 4.275

6.  SPINT2 Deregulation in Prostate Carcinoma.

Authors:  Márcia Santos Pereira; Gisele Caravina de Almeida; Filipe Pinto; Marta Viana-Pereira; Rui Manuel Reis
Journal:  J Histochem Cytochem       Date:  2015-10-06       Impact factor: 2.479

7.  Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.

Authors:  Mark R Morris; Eamonn R Maher
Journal:  Genome Med       Date:  2010-09-03       Impact factor: 11.117

8.  Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.

Authors:  Zhen Liu; Weiren Luo; Ying Zhou; Yan Zhen; Huiling Yang; Xiaoli Yu; Yanfen Ye; Xin Li; Hao Wang; Qinping Jiang; Yajie Zhang; Kaitai Yao; Weiyi Fang
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

9.  Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast Carcinoma.

Authors:  Qiulin Wu; Guobing Yin; Jing Luo; Yingzi Zhang; Tiantian Ai; Jiao Tian; Yudi Jin; Jinwei Lei; Shengchun Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-26       Impact factor: 5.555

10.  An integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiation.

Authors:  Tarmo Aijö; Sanna M Edelman; Tapio Lönnberg; Antti Larjo; Henna Kallionpää; Soile Tuomela; Emilia Engström; Riitta Lahesmaa; Harri Lähdesmäki
Journal:  BMC Genomics       Date:  2012-10-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.